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Gooley).AMP-activated protein kinase (AMPK) is a heterotrimer of catalytic (a) and regulatory (b and c) sub-
units with at least two isoforms for each subunit. AMPK b1 is widely expressed whilst AMPK b2 is
highly expressed in muscle and both b isoforms contain a mid-molecule carbohydrate-binding mod-
ule (b-CBM). Here we show that b2-CBM has evolved to contain a Thr insertion and increased afﬁnity
for glycogen mimetics with a preference for oligosaccharides containing a single a-1,6 branched
residue. Deletion of Thr-101 reduces afﬁnity for single a-1,6 branched oligosaccharides by 3-fold,
while insertion of this residue into the equivalent position in the b1-CBM sequence increases afﬁnity
by 3-fold, conﬁrming the functional importance of this residue.
 2010 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
The AMP-activated protein kinase (AMPK) is a heterotrimer of
a, b and c subunits, for each of which there are multiple isoforms.
The isoforms, encoded by seven genes (a1, a2, b1, b2, c1, c2, c3),
give rise to 12 possible isoenzymes that differ in tissue and subcel-
lular expression [1]. AMPK functions as a focal point for whole-
body and cellular mechanisms of energy homeostasis adapting
the body to new regimes of energy supply and demand, such as
during exercise (reviewed in [2]).
AMPK b1 is widely expressed whilst AMPK b2 is the predom-
inant and exercise-regulated b isoform in human skeletal muscle
[3]. We and others previously identiﬁed a mid-molecule protease-
resistant domain related to starch-binding modules in plants
within the AMPK b subunit [4,5] that is a member of the carbohy-
drate-binding module-containing family 48 (b-CBM) [6]. Inon behalf of the Federation of Euro
se; CBM, carbohydrate-bind-
gnetic resonance.
n), prg@unimelb.edu.au (P.R.addition, the b subunit is N-terminally myristoylated, phosphory-
lated on multiple residues [7] and contains a C-terminal ac-sub-
unit-binding sequence essential for heterotrimer formation [8].
The b-subunit CBM, in mammalian AMPK, binds glycogen
in vitro [5] and in cultured cells [4], and regulates the allosteric
inhibition of AMPK activity by glycogen and branched oligosac-
charides [9]. The crystal structure of the b1-CBM in complex with
the glycogen mimetic b-cyclodextrin, reveals a unique carbohy-
drate-binding pocket that incorporates all known aspects of car-
bohydrate-binding observed in starch-binding domains into the
one site. b-Cyclodextrin is held in a pincer-like grasp with two
tryptophan residues cradling two b-cyclodextrin glucose units
and a leucine residue piercing the b-cyclodextrin ring [10].
A molecular relationship between the activity and localization
of AMPK and glycogen metabolism has been well established. For
example, high muscle glycogen content is correlated with reduced
activation of AMPK by the AMP mimic, AICA riboside in perfused
rat muscle [11] and by exercise in human muscle [12]. In mamma-
lian cells AMPK co-immunoprecipitates with proteins including
glycogen synthase, glycogen phosphorylase and glycogen debran-
ching enzyme [13,14].
Glycogen is a branched polymer of glucose comprising of
a-1,4-glycosidic bonds with a-1,6-glycosidic linkages at branchpean Biochemical Societies.
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structures in muscle and liver. For example, muscle glycogen
consists of beta-particles with a diameter ranging in size from
20 to 50 nm, whilst liver glycogen consists of beta-particles that
aggregate to form much larger particles (with a diameter of
150–300 nm) known as alpha-rosettes [16]. Liver and muscle
glycogen also have different physiological roles; liver glycogen
is important for maintaining blood glucose whilst muscle glyco-
gen is important for providing glucose as a source of ATP for en-
ergy-requiring events like muscle contraction.
Previous studies to investigate the association of AMPK with
glycogen [5,9,10] or oligosaccharides [6] have examined the ubiq-
uitous b1 isoform, thus we decided to focus our attention on the
muscle-speciﬁc b2 isoform. We found that the b2-CBM has
evolved to bind oligosaccharides more tightly than the b1-CBM
with a preference for singly branched oligosaccharides like that
found during glycogen degradation. Recognition of branched
oligosaccharides is facilitated by a b2-CBM speciﬁc threonine
insertion. Collectively, these studies suggest that AMPK will dif-
ferentially associate with glycogen particles, which is dependent
on the b-subunit isoform, thus providing an opportunity to ther-
apeutically target AMPK speciﬁcally in muscle to ﬁght diseases
like type 2 diabetes and obesity.2. Materials and methods
2.1. Materials
Glycogen from bovine liver (Type IX), rabbit liver (Type III),
oyster (Type II), slipper limpet (Crepidula fornicata; Type VIII),
maltoheptaose and b-cyclodextrins were purchased from Sigma–
Aldrich (St. Louis, MO, USA). Anti-6-His antibodies were purchased
from Cell Signaling Technology (Beverly MA, USA). Secondary goat
anti-rabbit peroxidase conjugated antibodies were from Calbio-
chem (San Diego, CA, USA).2.2. Expression and puriﬁcation of AMPK b1-CBM and AMPK b2-CBM
AMPK b1-CBM was prepared as previously described [6].
AMPK b2-CBM (67–163) cDNA was ampliﬁed by PCR using the oli-
gonucleotides: sense, 50-GATTCTGTGAAGCCCACCCA-30; antisense
50-TCAATCAAATACTTCAAA-30. The ampliﬁed cDNA was cloned into
EcoR1 and Xho1 sites of the pProEX HT vector and positive clones
conﬁrmed by sequencing. AMPK b2-CBM was expressed and puri-
ﬁed as for AMPK b1-CBM [6].2.3. Site-directed mutagenesis
AMPK b1-CBM Thr-102 insertion and b2-CBM Thr-101 deletion
mutants were made by site-directed mutagenesis according to
manufacturer’s instructions (Stratagene) by using the template de-
scribed above. The sequences of the mutagenesis primers are avail-
able from the authors upon request.Fig. 1. AMPK b2-CBM associates tightly with glycogen. Thirty micrograms samples
of either AMPK b1- or b2-CBM were incubated alone or with rabbit, bovine, slipper
limpet (SL) or oyster glycogen bound to ConA–Sepharose for 60 min. Sepharose
beads were recovered by centrifugation and samples of the supernatant (S) and
pellet (P) analyzed by Western blot using an anti-His monoclonal antibody.2.4. Oligosaccharide synthesis
6-O-a-Glucosyl-b-cyclodextrin (glucosyl-b-cyclodextrin) and 6-
O-a-maltosyl-b-cyclodextrin (maltosyl-b-cyclodextrin) were pur-
chased from Wako (Wako Pure Chemical Industries Ltd., Tokyo,
Japan). 6-O-a-Maltotetraosyl-b-cyclodextrin (maltotetraosyl-b-
cyclodextrin) was enzymatically synthesized as previously de-
scribed [17]. Branched maltoheptaoses were obtained as described
previously [18].2.5. Fluorescence spectroscopy
Fluorescence was measured using a Cary Eclipse ﬂuorescence
spectrophotometer. Titrations were conducted at 25 C with CBM
concentrations in the range of 0.5–35 lM, in 25 mM sodium phos-
phate, pH 7.5. Aliquots of oligosaccharide were sequentially added
to CBM until further addition no longer elicited a quenching of the
ﬂuorescence (ﬁnal concentrations of ligands were 4–17 mM). The
volume change due to addition of ligand was not more than 10%
of the initial volume. Quintuplicate emission spectra were re-
corded from 300 to 380 nm, using an excitation wavelength of
295 nm. The emission intensity at 356 nm was extracted from
the spectrum and plotted as a function of the total ligand concen-
tration. Three titration datasets were performed on each ligand,
each at three different protein concentrations. The characteristic
intensity of the CBM–oligosaccharide complex in the three titra-
tions was then globally ﬁtted (GraphPad Prism v4.0a, GraphPad
Software Inc., San Diego, CA, USA) to extract a dissociation constant
(Kd), assuming a single ligand recognition site.
2.6. Nuclear magnetic resonance (NMR) spectroscopy
The binding of sugars to the CBMs were monitored by acquiring
heteronuclear multiple quantum correlation spectra (SOFAST-
HMQC [19]) for each titration point of increasing sugar concentra-
tion to protein. The initial concentration of protein used was
100 lM in 25 mM sodium phosphate, pH 7.5 and did not vary by
more than 10% over the titration. Final concentrations of ligands
varied between 3 and 15 mM. Titrations were carried out at
25 C on Bruker 800 MHz Avance II or 600 MHz Avance III spec-
trometers. The 1H, 13C, 15N assignments of the b1-CBM have been
determined using triple resonance methods [6]. The resonances
of the b2-CBM were similarly assigned (Koay et al., unpublished).
Dissociation constants were calculated using non-linear regression
by ﬁtting the titration data for individual 1H and 15N resonances
and assuming a single ligand recognition site
2.7. Phylogenetics
Sequences similar to AMPK b-subunits were collected using
BLAST and curated entries from Ensembl, the Arabidopsis Informa-
tion Resource TAIR, The Joint Genome Institute and GeneDB. Multi-
ple sequence alignment was carried out using MAFFT-L-INS-i [20],
and then manually adjusted and trimmed using JalView to produce
an alignment of 199 residues. Distance, parsimony and maximum
likelihood tree making methods were then used to infer trees using
PHYLIP PROTDIST, PROTPARS [21], and PhyML [22], respectively,
automated using custom-built BioRuby scripts [23].
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3.1. AMPK b2-CBM associates tightly with glycogen
The binding of glycogen to both AMPK b1- and b2-CBMs was
compared by utilizing a semi-quantitative, Sepharose bound Con-
canavalin A (ConA) assay [9] using two His6-tagged CBMs. Four
commercially available glycogens were bound to ConA-Sepharose
and the binding of b1- and b2-CBMs were compared (Fig. 1). We
found that the b1-CBM bound weakly to each commercial glycogenTable 1
Dissociation constants of glucosyl oligosaccharides binding to the carbohydrate binding m
Liganda Kd (l
b1-CB
FS
Maltoheptaose GGGGGGG 302 ±
Glucosyl-maltoheptaose
GGGGGGG 
G 
221 ±
Maltosyl-maltoheptaose GGGGGGG 
GG 346 ±
Maltotetraosyl-maltoheptaose
GGGGGGG 
GGGG 
564 ±
b-Cyclodextrin
G 
G G G 
G G G 5.5 ±
a All linkages are a-1,4 except at branch points which are a-1,6.
b Kd values were determined either by ﬂuorescence spectroscopy (FS) or NMR spectros
titrations performed at different protein concentrations. Each Kd determined by NMR wa
moderate to large chemical shift differences. In all ﬁts R2 did not fall below 0.99 except
c Titration of b-cyclodextrin to b2-CBM in NMR showed peaks in slow exchange, indi
Fig. 2. Bioinformatics analysis of AMPK b1- and b2-CBMs. (A) AMPK b2 subunit doma
ac-interaction domain (ac-SBS). The CBM has been expanded as shown to compare the s
black. Residues important for oligosaccharide binding are shown in yellow. (B) Bioinform
AMPK b1 are shown in blue with AMPK b2 shown in red.tested with the exception of bovine liver glycogen where tighter
binding was observed. However association of the b2-CBM with
glycogen showed complete binding to each glycogen tested sug-
gesting a tighter association.
3.2. The b2-CBM shows a preference for oligosaccharides with a single
a-1,6 branched residue
Given the differences in glycogen binding between the two
AMPK b isoforms we investigated the binding of b1- and b2-CBModules of the b1 and b2 isoforms of AMPK at 25 C.
M)b
M b2-CBM
NMR FS NMR
25 396 ± 9 55 ± 2 62 ± 3
20 254 ± 6 14 ± 1 15 ± 3
32 308 ± 8 73 ± 5 65 ± 5
40 601 ± 19 106 ± 5 131 ± 7
0.7 5.4 ± 1.7 <0.5c Slow ex.c
copy (NMR). Each Kd determined by FS values was obtained from a global ﬁt of three
s obtained from the ﬁt of 4–10 15NH and/or 15N peaks in fast exchange that showed
in b1-CBM with b-cyclodextrin (NMR), 0.98.
cative of sub-micromolar Kd and conﬁrmed by FS experiments (Kd < 0.5 lM).
in structure showing the location of the carbohydrate-binding domain (CBM) and
equence alignment between rat b1- and b2-CBMs. Conserved residues are shaded in
atics analysis of AMPK b1/b2 vertebrate homologues. Sequences recognized to be
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gosaccharide of seven a-1,4 linked glucosyl units) and a series of
linear oligosaccharides (Table 1). Both b-CBMs bound tightly to
b-cyclodextrin with afﬁnities in the low micromolar range for
b1-CBM and in the sub-micromolar range for b2-CBM. The linear
oligosaccharide maltoheptaose bound each b-CBM with weaker
afﬁnity compared to b-cyclodextrin, however, tighter binding
was observed for b2-CBM. Both b-CBMs showed an increase in
afﬁnity for a linear oligosaccharide with the addition of single a-
1,6 glucose unit (glucosyl-maltoheptaose) however, b2-CBM
showed 16-fold higher afﬁnity for this oligosaccharide compared
to b1-CBM. To determine the effect of increasing the branch length
we synthesized maltoheptaose with either a maltose-branch or
tetraose-branch and found decreasing afﬁnity to both b-CBMs,
however, tighter binding for all oligosaccharides was observed to
b2-CBM (Table 1).
3.3. Structural and bioinformatic comparison of b1- and b2-CBM
The ﬁnding that b2-CBM bound oligosaccharides signiﬁcantly
more tightly than the b1-CBM was an unexpected ﬁnding given
100% sequence identity (Fig. 2A) for the residues essential for oli-
gosaccharide binding [10]. To determine whether the divergence
between AMPK b1 and b2 carbohydrate binding afﬁnities was a rel-
atively recent or well-conserved event we assembled sequences of
AMPK b subunits from diverse eukaryote species. We ﬁnd that
AMPK b1 and b2 derive from a duplication of an ancestral AMPKFig. 3. (A) Overlay of b1-CBM (PDB: 1Z0M) with bound b-cyclodextrin in blue and
b2-CBM (PDB: 2F15) structures. (B) The structures are rotated by about 90-degree
around the y-axis. The b1-CBM structure is in magenta and cyan and b2-CBM in
yellow and green. The Thr-101 insertion found in b2-CBM is indicated and although
remote from the carbohydrate-binding site affects the position of the loop structure
and the preceding Trp residue (Trp-99) that is a part of the oligosaccharide-binding
site. The essential Trp residues within the carbohydrate-binding site are shown for
both CBMs. (C) Comparison of the afﬁnity for maltoheptaose and glucosyl-
maltoheptaose by wild type b1- and b2-CBM and the mutants where Thr-101 has
been deleted from b2-CBM (DThr-101 b2-CBM) and inserted into the b1-CBM (Thr-
102ins b1CBM). Data measured are expressed as mean ± S.E.M. (n = 3). Data were
subjected to two-way ANOVA with protein and sugar as between-subject variables
(***P < 0.001).b subunit near the base of the vertebrate lineage (Fig. 2B) prior
to the diversiﬁcation of ﬁsh, amphibians, reptiles, birds and mam-
mals. Surprisingly we ﬁnd that the AMPK b homologs in both yeast
and plants lie well out of these b1 and b2 families.
Furthermore, close inspection of available b-CBM structures
([10], PDB 2F15) does not show a clear structural reason for this
difference in binding, nor allow prediction of the effect of branch-
ing on the structure or the packing of the a-1,6 branch against the
protein modules. A signiﬁcant difference between the sequences of
the b1- and b2-CBMs includes a single threonine insertion at posi-
tion 101 in AMPK b2 after Trp-99. The latter residue has been
shown to be essential for oligosaccharide binding and glycogen
association in vitro [5,9,10]. The insertion of Thr-101 (Fig. 3A and
B) may have a signiﬁcant effect on the motion of the protein and
its ligand binding properties. To investigate the role of Thr-101
we inserted this residue into the b1-CBM (Thr-102ins b1-CBM)
whilst deleting it from the b2-CBM (DThr-101 b2-CBM) and deter-
mined binding afﬁnity for maltoheptaose and glucosyl-maltohep-
taose (Fig. 3C). We found a modest increase in afﬁnity for
maltoheptaose between wild type b1-CBM and protein containing
the Thr insertion (302 ± 25 lM vs. 188 ± 7 lM), and a similar de-
crease in afﬁnity between wild type b2-CBM and protein contain-
ing the Thr deletion (55 ± 2 lM vs. 73 ± 3 lM). However, titration
of b1-CBM containing the Thr insertion with glucosyl-maltohepta-
ose shows a signiﬁcant 3-fold increase in afﬁnity for this branched
oligosaccharide (221 ± 20 lM vs. 71 ± 4 lM), whilst titration of the
b2-CBM containing the Thr deletion led to the opposite effect and a
signiﬁcant 3-fold decrease in afﬁnity (14 ± 1 lM vs. 40 ± 2 lM).
These data support the importance of the Thr insertion in deﬁning
the speciﬁcity difference of these two CBMs.
4. Discussion
Protein–carbohydrate recognition plays a pivotal role in key
biological processes. There are 59 known CBMs with roles as di-
verse as host–pathogen recognition, protein trafﬁcking, cell–cell
communication and polysaccharide hydrolysis [24]. Six CBM fam-
ilies are represented in mammals, CBM13, CBM14, CBM20, CBM21,
CBM48 and CBM57 with CBM48 domains residing within the
AMPK b subunit [25]. AMPK CBMs have previously been shown
to associate with glycogen in vitro [5,10] and in cultured cells
[4,5] but more recently have been hypothesized to act as sensors
of the structural state of cellular glycogen [9]. Here we show that
the AMPK b2 subunit, compared to the b1 subunit, has evolved
to possess a CBM that has a higher afﬁnity for oligosaccharides
similar to those found in glycogen. For the linear and linear-
branched oligosaccharides the b2-CBM compared to the b1-CBM
showed between 4- and 16-fold tighter binding with the largest
difference observed for the single a-1,6 branched glucosyl-malto-
heptaose. Comparing the relative afﬁnities for the oligosaccharides
to each CBM show that b1-CBM binds with less than a 2-fold in-
crease in afﬁnity for glucosyl-maltoheptaose over maltoheptaose,
whereas b2-CBM shows a 4-fold increase in afﬁnity. The X-ray
crystal structure of the b1-CBM [10] indicates that the van der
Waals contacts between Trp-99, Trp-133, and Leu-146 to the b-
cyclodextrin, and hydrogen bonds from the side chains of Lys-
126, Thr-148 and Asn-150 to b-cyclodextrin are conserved, and
no additional interactions are obvious. Inspection of the residues
that differ between the two isoforms reveals a threonine insertion
in the b2-CBM at position 101. This residue is distant from the car-
bohydrate-binding site but may alter the main chain such that the
side chains of residues that contact the oligosaccharides make bet-
ter contacts. The threonine insertion is clearly not a recent event in
evolutionary history given these isoforms diverged near the base of
the vertebrate lineage (Fig. 3B) prior to the diversiﬁcation of ﬁsh,
amphibians, reptiles, birds and mammals. Deletion of Thr-101 in
A. Koay et al. / FEBS Letters 584 (2010) 3499–3503 3503the b2-CBM and inserting this residue into the b1-CBM had only a
minor effect on the afﬁnity of these mutants for maltoheptaose but
a signiﬁcant effect on the afﬁnity for glucosyl-maltoheptaose. This
result, and the data in Table 1, is consistent with AMPK containing
b2-subunits binding preferentially to the glucosyl polymeric struc-
tures commonly found in glycogen.
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